Sorrento Therapeutics, Inc.

SRNE · OTC
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Assets
Cash & Equivalents$69,749$37,655$23,634$70,686
Short-Term Investments$10,886$12,662$26,344$47,175
Receivables$32,725$26,524$24,469$24,190
Inventory$9,651$11,308$9,976$17,961
Other Curr. Assets$4,878$4,784$3,143$9,008
Total Curr. Assets$133,111$100,760$96,373$176,957
Property Plant & Equip (Net)$106,645$140,259$138,435$128,895
Goodwill$80,269$80,269$80,269$80,199
Intangibles$122,283$123,875$136,902$171,440
Long-Term Investments$12,008$12,008$17,176$55,605
Tax Assets$0$0$0$0
Other NC Assets$2,376$2,892$3,685$2,518
Total NC Assets$323,581$359,303$376,467$438,657
Other Assets$0$0$0$0
Total Assets$456,692$460,063$472,840$615,614
Liabilities
Payables$18,554$14,590$47,515$38,391
Short-Term Debt$120,362$63,685$16,286$66,280
Tax Payable$12,926$12,148$0$0
Deferred Revenue$256$252$652$281
Other Curr. Liab.$912$55,593$8,197$54,458
Total Curr. Liab.$264,949$165,632$327,922$201,980
LT Debt$21,741$21,400$19,130$17,800
Deferred Rev, NC$896$983$7,098$117,224
Deferred Tax Liab, NC$238$238$591$1,744
Other NC Liab.$314,378$314,768$54,560$62,527
Total NC Liab.$389,699$421,851$166,587$283,428
Other Liabilities$0$0$0$0
Cap. Leases$65,497$98,512$99,088$97,506
Total Liabilities$654,648$587,483$494,509$485,408
Equity
Pref Stock$0$0$0$0
Common Stock$55$55$52$47
Retained Earnings-$2,194,275-$2,099,063-$1,959,447-$1,735,755
AOCI$2,240$1,826$1,501$226
Other Equity$0$0$0$0
Total Equity-$205,113-$125,498-$18,605$131,848
Supplemental Information
Minority Interest$7,157-$1,922-$3,064-$1,642
Total Liab. & Tot. Equity$456,692$460,063$472,840$615,614
Net Debt$72,354$47,430$11,782$13,394
Sorrento Therapeutics, Inc. (SRNE) Financial Statements & Key Stats | AlphaPilot